www.scienceboard.org The Science Advisory Board - Protocols, Product Reviews, Member Forum, and Science News
Note: You are seeing this message either because your browser has not loaded our stylesheets, or because your browser does not support stylesheets (CSS). Please upgrade to a relatively modern browser to improve your experience. Not sure what to upgrade to? Try Firefox.
The Science Advisory Board
Screen Name: 
 
Password: 
 

Current Studies
The Science Advisory Board attempts to have at least one study ongoing at all times. Members are invited to studies by email invitations that include a unique URL to access the study questionnaire. Many factors influence which members are invited to a particular study, including but not limited to expertise and tools and techniques indicated in the Member Profile, geographic region and number of responses needed for a particular topic. Studies may remain open for 2-14 days.

Future Studies
    - Genomic Technologies
    - Structural Characterization of Membrane Proteins
    - RNA Inhibition
    - The Federal Procurement Market
    - Molecular Imaging
    - Cellular Imaging and Detection
    - Cell Signaling
    - Biomarkers in Drug Discovery
    - Personalized Medicine/Companion Diagnostics

This is a partial list of topics The Science Advisory Board plans to examine over the coming months. If you would like to suggest a study topic you think would be of interest to Science Advisory Board members, please contact questions@scienceboard.net.
Active Members
68,367

The Science Advisory Board is the world's original professional network of life scientists.

Members of the SAB:

  • Connect with other scientists.

  • Find tips, methodologies and procedures from established researchers.

  • Share insights, stories, jokes and even "gripes" in an open environment.

  • Voice opinions on companies and products used in their work.

  • Earn generous rewards for their opinions.

Practicing life science researchers and medical professionals participate in The Science Advisory Board's studies, forums, news articles and social media channels.